Debt to Equity Ratio Chart

Historical Debt to Equity Ratio Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2024 -0.7842
March 31, 2024 -0.8419
December 31, 2023 -0.7293
September 30, 2023 -0.7413
June 30, 2023 -0.7727
March 31, 2023 -0.6126
December 31, 2022 -0.6281
September 30, 2022 -0.648
June 30, 2022 -0.6645
March 31, 2022 -0.6593
December 31, 2021 -0.6593
September 30, 2021 -0.6792
June 30, 2021 -0.5907
March 31, 2021 -0.5933
December 31, 2020 -0.5672
September 30, 2020 -0.594
June 30, 2020 -0.5952
March 31, 2020 -0.6356
December 31, 2019 -0.6599
September 30, 2019 -0.7137
June 30, 2019 -0.7414
March 31, 2019 -0.8248
December 31, 2018 -0.817
September 30, 2018 -0.8249
June 30, 2018 -0.8275
Date Value
March 31, 2018 -0.8896
December 31, 2017 -0.9005
September 30, 2017 -0.9216
June 30, 2017 -0.739
March 31, 2017 -0.5548
December 31, 2016 -0.6575
September 30, 2016 -0.3124
June 30, 2016 -0.2104
March 31, 2016 -0.0971
December 31, 2015 -0.0538
September 30, 2015 -0.7085
June 30, 2015 -0.8214
March 31, 2015 -0.383
December 31, 2014 -0.5268
September 30, 2014 -0.6003
June 30, 2014 -0.3837
March 31, 2014 -0.1872
December 31, 2013 -0.2399
September 30, 2013 -0.3354
June 30, 2013 -0.1707
March 31, 2013 -0.292
December 31, 2012 -0.6733
September 30, 2012 -0.7076
June 30, 2012 -0.2009
March 31, 2012 -0.3242

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Agilent Technologies, Inc. 0.5363
Bio-Rad Laboratories, Inc. 0.191
Bruker Corp. 0.7663
Danaher Corp. 0.5298
Harvard Bioscience, Inc. 5.959